Drug Channels

MAY 10, 2022

Time for Drug Channels ’ annual update on pricing at the largest pharmaceutical manufacturers. When rebates and discounts were factored in, brand-name drug prices declined—or grew slowly—in 2021. That’s why I refer to them as drug pricing flat earthers (#DPFE). d/b/a Drug Channels Institute.

Drug Pricing 98

Drug Pricing Pharmaceutical Manufacturing 98

Drug Channels

JULY 28, 2022

Time for Drug Channels ’ annual update on pricing at the largest pharmaceutical manufacturers. When rebates and discounts were factored in, brand-name drug prices declined—or grew slowly—in 2021. That’s why I refer to them as drug pricing flat earthers (#DPFE). d/b/a Drug Channels Institute.

Drug Pricing 98

Drug Pricing Pharmaceutical Manufacturing 98

Drug Channels

OCTOBER 4, 2023

Time for Drug Channels ’ annual update on pricing at the largest pharmaceutical manufacturers. When rebates and discounts were factored in, brand-name drug prices again declined—or grew slowly—in 2022. But for now, the 2022 data provide fresh inconvenient facts for the drug pricing flat earthers (#DPFE).

Drug Pricing 98

Drug Pricing Pharmaceutical Manufacturing 98

Drug Channels

JUNE 13, 2023

Time for Drug Channels ’ annual update on pricing at the largest pharmaceutical manufacturers. When rebates and discounts were factored in, brand-name drug prices again declined—or grew slowly—in 2022. But for now, the 2022 data provide fresh inconvenient facts for the drug pricing flat earthers (#DPFE).

Drug Pricing 98

Drug Pricing Pharmaceutical Manufacturing 98

Drug Channels

MAY 20, 2025

2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Purchasers who violate this limitation by recording, streaming, sharing, or projecting a DCI webinar to other sites, devices, or locations will be liable for the full cost of all locations that viewed the webinar. All rights reserved.

Drug Pricing 75

Drug Pricing Pharmaceutical Manufacturing Hospitals 75

Drug Channels

JULY 23, 2024

It’s time for Drug Channels ’ annual update on pricing at the largest pharmaceutical manufacturers. These data remain inconvenient for drug pricing flat earthers (#DPFE): When rebates and discounts were factored in, brand-name drug prices again declined—or grew slowly—in 2023.

Drug Pricing 52

Drug Pricing Pharmaceutical Manufacturing Biosimilars 52

Drug Channels

AUGUST 11, 2020

Time for our annual update on pricing at five of the largest pharmaceutical manufacturers—Eli Lilly, Janssen, Merck, Novartis, and Sanofi. When rebates and discounts were factored in, drug prices declined—or grew slowly—in 2019. Read more » Copyright © 2006-2020 Pembroke Consulting, Inc.

Drug Pricing 52

Drug Pricing Pharmaceutical Manufacturing 52